Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.6%

1 terminated out of 39 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

15%

6 trials in Phase 3/4

Results Transparency

7%

1 of 15 completed with results

Key Signals

1 with results94% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (17)
Early P 1 (1)
P 1 (3)
P 2 (3)
P 3 (4)
P 4 (2)

Trial Status

Completed15
Unknown10
Recruiting7
Not Yet Recruiting3
Active Not Recruiting2
Terminated1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (39)

Showing 20 of 20 trials
NCT07283614Not ApplicableActive Not RecruitingPrimary

Ocular Hypotony and Refractive Predictability in RRD Surgery

NCT07054281Not ApplicableWithdrawn

UNITY VCS Vitreoretinal Surgery

NCT06425419Phase 1Not Yet Recruiting

The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy

NCT06033703Phase 1RecruitingPrimary

Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

NCT07162818Phase 4Completed

Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy

NCT07081945Not ApplicableRecruitingPrimary

hAM for Inferior RRD

NCT05331664Phase 4RecruitingPrimary

Dropless Pars Plana Vitrectomy Study

NCT06997874Phase 3RecruitingPrimary

Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract Removal

NCT06919211Not ApplicableCompletedPrimary

Perfluorocarbon Liquid vs. Posterior Retinotomy During Pars-plana Vitrectomy for Rhegmatogenous Retinal Detachment

NCT06826573RecruitingPrimary

Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence After Vitrectomy with Silicone Oil Tamponade in Retinal Detachment Patients

NCT06694259Not ApplicableRecruitingPrimary

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

NCT06610786Not ApplicableNot Yet RecruitingPrimary

Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment

NCT06541574Phase 2Recruiting

Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

NCT06056596Early Phase 1Terminated

Lamivudine and Plasma Markers of Inflammation in Retinal Detachment

NCT05660447Phase 2Active Not RecruitingPrimary

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

NCT06324305Not ApplicableNot Yet RecruitingPrimary

Comparative Study Between Three Different Techniques in Drainage of SRF During PPV in RRD

NCT04891991Phase 2CompletedPrimary

Intravitreal Infliximab for Proliferative Vitreoretinopathy

NCT05377606Not ApplicableCompletedPrimary

Primary Vitrectomy With Silicone Oil or SF6 for Rhegmatogenous Retinal Detachment

NCT04723420Not ApplicableUnknownPrimary

Pneumatic Retinopexy for Primary Rhegmatogenous Retinal Detachment: To Steamroll or Not

NCT01845571UnknownPrimary

Retinal Detachment - Demographic and Clinical Survey

Scroll to load more

Research Network

Activity Timeline